MRO has acquired Clinetic, a recruitment management platform, in a move aimed at improving patient recruitment processes for clinical trials. The financial terms of the acquisition remain undisclosed. This strategic acquisition is part of MRO’s commitment to enhancing its “smarter data” capabilities by integrating Clinetic’s advanced AI-driven software.
Enhancing Clinical Trial Recruitment through Technology
Clinetic is recognized as a leading platform that aids healthcare organizations and life sciences companies in identifying, screening, and enrolling patients for clinical trials more efficiently. The integration of Clinetic’s software into MRO’s operations will utilize real-time data from Electronic Health Records (EHR) to streamline the recruitment process.
The software addresses the common challenges many hospitals face regarding resource limitations and technological barriers. By establishing secure connections within provider EHR systems, Clinetic’s platform allows direct access to comprehensive historical and clinical data needed to satisfy specific clinical trial protocols.
Research teams can leverage this real-time data to identify eligible patients across various therapeutic areas, build more precise cohorts, and plan studies with increased confidence.
Tom Kaminski, CEO of Clinetic, emphasized the compatibility of the two organizations, stating, “Clinetic has strong roots in healthcare, already evaluating the data of more than 15 million patients across the US. Joining MRO was a natural fit, considering our joint focus on transforming unstructured clinical data into actionable data sets and our unwavering commitment to our hospital partners and the communities they serve.”
Implications for the Future of Clinical Trials
The acquisition marks a significant step in addressing the complexities of patient recruitment in clinical trials, a process often hindered by inefficiencies and outdated methodologies. By harnessing AI technology and EHR data, MRO aims to facilitate faster and more accurate recruitment, ultimately improving trial outcomes.
As clinical trials grow increasingly crucial in the development of new therapies and treatments, the ability to efficiently recruit and enroll patients will play a vital role in the success of these initiatives. This acquisition not only strengthens MRO’s position in the healthcare data landscape but also signals a promising advancement in how clinical trials may be conducted in the future.
MRO’s focus on smarter data through the acquisition of Clinetic underscores a growing trend within the healthcare industry to leverage technology for enhanced patient care and operational efficiency. With this integration, MRO is poised to set a new standard for patient recruitment processes in clinical research.
